Compare SHASUN PHARMA with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA AJANTA PHARMA SHASUN PHARMA/
AJANTA PHARMA
 
P/E (TTM) x 123.9 27.4 451.5% View Chart
P/BV x 8.5 7.6 111.9% View Chart
Dividend Yield % 0.2 0.5 50.4%  

Financials

 SHASUN PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
AJANTA PHARMA
Mar-19
SHASUN PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs941,422 6.6%   
Low Rs46898 5.1%   
Sales per share (Unadj.) Rs214.2233.5 91.7%  
Earnings per share (Unadj.) Rs5.344.0 12.1%  
Cash flow per share (Unadj.) Rs15.852.2 30.3%  
Dividends per share (Unadj.) Rs1.009.00 11.1%  
Dividend yield (eoy) %1.40.8 184.4%  
Book value per share (Unadj.) Rs53.3255.1 20.9%  
Shares outstanding (eoy) m56.6288.02 64.3%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.35.0 6.6%   
Avg P/E ratio x13.126.4 49.7%  
P/CF ratio (eoy) x4.422.2 19.9%  
Price / Book Value ratio x1.34.5 28.8%  
Dividend payout %18.720.5 91.5%   
Avg Mkt Cap Rs m3,958102,081 3.9%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m2,1644,307 50.2%   
Avg. sales/employee Rs ThNM3,022.6-  
Avg. wages/employee Rs ThNM633.4-  
Avg. net profit/employee Rs ThNM569.1-  
INCOME DATA
Net Sales Rs m12,12720,554 59.0%  
Other income Rs m229211 108.8%   
Total revenues Rs m12,35620,765 59.5%   
Gross profit Rs m1,0095,664 17.8%  
Depreciation Rs m594721 82.4%   
Interest Rs m41512 3,578.4%   
Profit before tax Rs m2305,143 4.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-731,273 -5.7%   
Profit after tax Rs m3023,870 7.8%  
Gross profit margin %8.327.6 30.2%  
Effective tax rate %-31.724.8 -127.9%   
Net profit margin %2.518.8 13.2%  
BALANCE SHEET DATA
Current assets Rs m6,88411,812 58.3%   
Current liabilities Rs m8,4563,776 223.9%   
Net working cap to sales %-13.039.1 -33.1%  
Current ratio x0.83.1 26.0%  
Inventory Days Days6277 79.6%  
Debtors Days Days10882 131.8%  
Net fixed assets Rs m4,97014,398 34.5%   
Share capital Rs m113175 64.6%   
"Free" reserves Rs m2,87522,277 12.9%   
Net worth Rs m3,02022,452 13.5%   
Long term debt Rs m1,8177 27,536.4%   
Total assets Rs m13,34726,962 49.5%  
Interest coverage x1.6444.3 0.3%   
Debt to equity ratio x0.60 204,704.7%  
Sales to assets ratio x0.90.8 119.2%   
Return on assets %5.414.4 37.3%  
Return on equity %10.017.2 58.0%  
Return on capital %13.323.0 58.1%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84310,682 54.7%   
Fx outflow Rs m2,1732,102 103.4%   
Net fx Rs m3,6698,580 42.8%   
CASH FLOW
From Operations Rs m3983,748 10.6%  
From Investments Rs m-1,635-2,228 73.4%  
From Financial Activity Rs m1,309-1,475 -88.7%  
Net Cashflow Rs m7145 157.5%  

Share Holding

Indian Promoters % 39.2 73.8 53.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 1.6 232.3%  
FIIs % 17.6 7.6 231.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 17.0 232.9%  
Shareholders   20,750 20,968 99.0%  
Pledged promoter(s) holding % 12.3 4.4 280.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ALEMBIC  SUN PHARMA  PIRAMAL ENTERPRISES  FDC  AUROBINDO PHARMA  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 424 Points Higher; Sun Pharma and UPL Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS